WGS Q4 2021 Earnings — GeneDx Holdings Corp. Revenue & Financial Results | Market Cap Arena

WGSGeneDx Holdings Corp.

$3B

Q4 2021 Earnings

Healthcare Medical - Healthcare Information Services

Income Statement

Revenue

$58M-9.6% YoY

Gross Profit

$9M15.9% margin

Operating Income

-$116M-200.7% margin

Net Income

-$40M-69.9% margin

EPS (Diluted)

$-5.49

QoQ Revenue Growth

+33.9%

Cash Flow

Operating Cash Flow

-$52M

Free Cash Flow

-$57M

Stock-Based Comp.

$37M

Balance Sheet

Total Assets

$554M

Total Liabilities

$166M

Stockholders' Equity

$388M

Cash & Equivalents

$401M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$58M	$64M	-9.6%
Gross Profit	$9M	$415,000	+2116.6%
Operating Income	-$116M	-$125M	+7.2%
Net Income	-$40M	-$126M	+67.8%